Mannkind (MNKD) Current Deferred Revenue (2014 - 2026)

Mannkind (MNKD) reported Current Deferred Revenue of $11.5 million for Q1 2026, down 1.97% year-over-year from $11.8 million in Q1 2025, and down 24.83% quarter-over-quarter from $15.3 million in Q4 2025.

Mannkind (MNKD) Current Deferred Revenue (2014 - 2026) Analysis & Trends

Mannkind (MNKD) has 13 years of Current Deferred Revenue data on file, last reported at $11.5 million in Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $11.5 million, down 1.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.5 million (down 1.97% YoY), and the FY2025 annual result was $15.3 million, up 23.57% from the prior year.
  • Current Deferred Revenue retreated to $11.5 million in Q1 2026 per MNKD's latest filing, from $15.3 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $78.9 million in Q4 2023 and troughed at $1.3 million in Q1 2022.
  • A 5-year average of $19.1 million and a median of $10.1 million in 2025 frame the typical range for Current Deferred Revenue.
  • The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue sank 94.95% in 2022, then soared 5829.61% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $63.6 million in 2022, then increased by 24.09% to $78.9 million in 2023, then tumbled by 84.27% to $12.4 million in 2024, then climbed by 23.57% to $15.3 million in 2025, then decreased by 24.83% to $11.5 million in 2026.
  • Business Quant data shows MNKD's Current Deferred Revenue at $11.5 million in Q1 2026, $15.3 million in Q4 2025, and $10.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.53 Mn
Dec 31, 2025 15.33 Mn
Sep 30, 2025 10.12 Mn
Jun 30, 2025 10.95 Mn
Mar 31, 2025 11.76 Mn
Dec 31, 2024 12.41 Mn
Sep 30, 2024 6.52 Mn
Jun 30, 2024 7.42 Mn
Mar 31, 2024 7.60 Mn
Dec 31, 2023 78.88 Mn
Sep 30, 2023 3.67 Mn
Jun 30, 2023 3.49 Mn
Mar 31, 2023 77.50 Mn
Dec 31, 2022 63.57 Mn
Sep 30, 2022 1.79 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 1.31 Mn
Dec 31, 2021 20.37 Mn
Sep 30, 2021 14.02 Mn
Jun 30, 2021 20.13 Mn